Sign In
Free Newsletter
NJ Assembly advances PBM reform bill to cut drug costs
The New Jersey General Assembly advanced a measure that aims to lower prescription drug costs, increase transparency and regulate PBMs in New Jersey's healthcare system.
Leaders preview NJ Innovation Hub at HELIX
Leaders preview the HELIX NJ Innovation Hub in New Brunswick, highlighting life sciences collaboration, startup support – and why New Brunswick is an ideal location for the facility.
BioNJ to join NJ Innovation Hub at HELIX New Brunswick
BioNJ will join the NJ Innovation Hub at HELIX in New Brunswick, boosting life sciences collaboration and startup growth.
Trump 100% pharma tariffs raise concerns for New Jersey life sciences (updated)
The president's levies on imported drugs and ingredients raise concerns for New Jersey’s life sciences sector, with risks to costs and innovation.
Business groups react to Sherrill’s $60.7B NJ budget, mixed reviews (updated)
Business groups and policy advocates are weighing in on Gov. Mikie Sherrill’s $60.7 billion spending plan, applauding cuts and reforms while noting tax concerns.
Tylenol use in pregnancy fell after Trump remarks, study finds
New Jersey experts weigh in on a new Lancet study showing a drop in Tylenol use among pregnant women after controversial White House claims. Experts urge science-based guidance.
BioNJ unveils roadmap to boost NJ life sciences leadership
BioNJ released a white paper outlining an eight-year strategy to enhance New Jersey's life sciences sector by elevating its profile, strengthening startups, attracting talent, boosting manufacturing and expanding into adjacent sectors.
BioNJ elects Genmab’s Cozic as 2026 board chair
Genmab Executive Vice President Christopher Cozic will serve as chair, following his unanimous election during the life sciences association's annual meeting in East Brunswick.
BioNJ dinner honors life sciences leaders, Sherrill keynotes
Gov. Mikie Sherrill delivered the keynote at the annual event, which highlighted awards, breakthroughs and industry innovators.
OPINION: How New Jersey is leading AI innovation in life sciences
The Garden State is emerging as a national pioneer in artificial intelligence-driven advances in the field, transforming health care, drug discovery and biomanufacturing.
BioNJ’s Hart on policy, AI and what’s next for NJ life sciences
NJBIZ continues the conversation with CEO Debbie Hart, who discusses tariffs, technology, manufacturing and the most exciting developments in the industry.
BioNJ’s Hart talks investment, innovation in NJ
Debbie Hart sits down with NJBIZ to discuss life sciences growth here, changing gubernatorial administrations, and highlight state initiatives and opportunities helping to serve patients.
